Mercado de equipamentos de descongelação de terapia celular e genética Ásia-Pacífico – Tendências do setor e previsão para 2028

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado de equipamentos de descongelação de terapia celular e genética Ásia-Pacífico – Tendências do setor e previsão para 2028

  • Healthcare
  • Publish Reports
  • Sep 2021
  • Asia-Pacific
  • 350 Páginas
  • Número de tabelas: 141
  • Número de figuras: 55

Mercado de equipamentos de descongelação de terapia celular e genética Ásia-Pacífico, por modalidade (bancada e portátil), amostra (terapias celulares e terapias genéticas), tipo ( sistema de descongelação manual e sistema de descongelação automática), aplicação (processamento upstream e processamento downstream), utilizador final ( Bancos de Sangue e Centros de Transfusão, Hospitais e Laboratórios de Diagnóstico, Laboratórios de Investigação e Institutos Académicos, Biotecnologia e Indústria Farmacêutica , Bancos de Sangue de Cordão e Células Estaminais, Bancos de Genes e Outros), Canal de Distribuição (Concurso Direto, Distribuidor Terceirizado e Outros), País (China, Coreia do Sul, Japão, Índia, Austrália, Singapura, Malásia, Indonésia, Tailândia, Filipinas, Resto da Ásia-Pacífico) Tendências e previsões da indústria para 2028.

Mercado de equipamentos de descongelação de terapia celular e genética da Ásia-PacíficoAnálise de mercado e insights: Mercado de equipamentos de descongelação de terapia celular e genética da Ásia-Pacífico

Espera-se que o mercado de equipamentos de descongelação de terapia celular e genética ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 14,2% no período de previsão de 2021 a 2028 e prevê-se que atinja os 1.771,29 milhões de dólares até 2028. O aumento de casos de doenças genéticas, como doenças cardíacas, fibrose quística e SIDA, exige equipamentos avançados de descongelamento de terapia celular e genética, atuando assim como impulsionador para o crescimento do mercado de equipamentos de descongelação de terapia celular e genética.

Os equipamentos de descongelação de terapia celular e genética tornaram-se fáceis devido ao avanço da tecnologia, uma vez que vários dos principais players do mercado estão a desenvolver e a lançar novas soluções para expandir o seu mercado. Além disso, o aumento dos gastos em saúde nos países desenvolvidos, bem como nos países em desenvolvimento, alimentou o crescimento do mercado de equipamentos de descongelação para terapia celular e genética. O mercado de equipamentos de descongelação para terapia celular e genética está a crescer devido ao aumento da incidência de doenças crónicas e ao aumento do avanço tecnológico.

O aumento da prevalência de doenças crónicas atua como impulsionador do mercado de equipamentos de descongelação para terapia celular e genética. O aumento do custo associado à engenharia de terapia celular e genética reduz a procura de equipamentos de descongelação de terapia celular e genética, o que está a restringir o crescimento do mercado de equipamentos de descongelação de terapia celular e genética. O aumento dos novos avanços tecnológicos atua como uma oportunidade para o mercado de equipamentos de descongelação de terapia celular e genética. No entanto, a falta de acessibilidade nos países de baixo e médio rendimento atua como um desafio para o crescimento do mercado de equipamentos de descongelação de terapia celular e genética.

O relatório de mercado de equipamentos de descongelação de terapia celular e genética fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos, decisões estratégicas , lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado de equipamentos de descongelação de terapia celular e genética, contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.

Mercado de equipamentos de descongelação de terapia celular e genética da Ásia-PacíficoÂmbito do mercado e tamanho do mercado de equipamentos de descongelação de terapia celular e genética

O mercado de equipamentos de descongelação de terapia celular e genética está segmentado com base na modalidade, amostra, tipo, aplicação, utilizador final, canal de distribuição. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.

  • Com base na amostra, o mercado de equipamentos de descongelação para terapia celular e genética está segmentado em terapias celulares e terapias genéticas. Em 2021, prevê-se que o segmento da terapia celular domine o mercado de equipamentos de descongelação de terapia celular e genética devido ao aumento da prevalência e incidência de cancro. 
  • Com base no tipo, o mercado de equipamentos de descongelação para terapia celular e genética está segmentado em sistema de descongelação manual e sistema de descongelação automática. Em 2021, prevê-se que o segmento dos sistemas de descongelação automática domine o mercado de equipamentos de descongelação para terapia celular e genética, uma vez que melhora a reprodutibilidade e minimiza o erro humano. 
  • Com base na aplicação, o mercado de equipamentos de descongelação para terapia celular e genética está segmentado em processamento upstream e processamento downstream. Em 2021, prevê-se que o segmento de processamento a montante domine o mercado de equipamentos de descongelação para terapia celular e genética devido aos crescentes avanços tecnológicos nos sistemas de descongelação. 
  • Com base no utilizador final, o mercado de equipamentos de descongelação para terapia celular e genética está segmentado em bancos de sangue e centros de transfusão, hospitais e laboratórios de diagnóstico, laboratórios de investigação e institutos académicos, biotecnologia e indústria farmacêutica, bancos de sangue do cordão umbilical e células estaminais, bancos de genes e outros. Em 2021, prevê-se que o segmento dos bancos de sangue domine o mercado de equipamentos de descongelação de terapia celular e genética devido ao aumento do número de bancos de sangue e de prestadores de cuidados de saúde avançados nos países de baixo e médio rendimento.
  • Com base no canal de distribuição, o mercado de equipamentos de descongelação para terapia celular e genética está segmentado em licitação direta, distribuidor terceirizado e outros. Em 2021, prevê-se que o segmento de licitação direta domine o mercado de equipamentos de descongelamento de terapia celular e genética, uma vez que a maioria dos equipamentos de descongelamento de terapia celular e genética adquiridos pelos prestadores de cuidados de saúde diretamente na licitação direta.

Análise ao nível do país do mercado de equipamentos de descongelação de terapia celular e genética

O mercado de equipamentos de descongelação de terapia celular e genética está segmentado com base na modalidade, amostra, tipo, aplicação, utilizador final, canal de distribuição.

Os países abrangidos no relatório de mercado de equipamentos de descongelação de terapia celular e genética são o Japão, a Índia, a Austrália, Singapura, a Malásia, a Indonésia, a Tailândia, as Filipinas e o resto da Ásia-Pacífico.

A China está a liderar o crescimento do mercado Ásia-Pacífico e o segmento de bancada está a dominar neste país devido à presença do maior número de fornecedores de equipamentos de descongelação de terapia celular e genética. 

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, a presença e disponibilidade de marcas globais e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, o impacto dos canais de vendas são considerados, ao mesmo tempo que fornece uma análise de previsão dos dados do país.

O crescimento das atividades estratégicas dos principais players do mercado para aumentar a sensibilização para os equipamentos de descongelação de terapia celular e genética está a impulsionar o crescimento do mercado de equipamentos de descongelação de terapia celular e genética

O mercado de equipamentos de descongelação para terapia celular e genética também fornece análises de mercado detalhadas para o crescimento de cada país num mercado específico. Além disso, fornece informações detalhadas sobre a estratégia dos intervenientes no mercado e a sua presença geográfica. Os dados estão disponíveis para o período histórico de 2010 a 2019.

Cenário competitivo e análise da quota de mercado de equipamentos de descongelação de terapia celular e genética

O panorama competitivo do mercado de equipamentos de descongelação de terapia celular e genética fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura e amplitude do produto, domínio de aplicação, curva de segurança da tecnologia. Os dados fornecidos acima estão apenas relacionados com o foco da empresa relacionado com o mercado de equipamentos de descongelação para terapia celular e genética.

As principais empresas que lidam com equipamentos de descongelação para terapia celular e genética são a Pluristem Therapeutics Inc., Genesis BPS, Eppendorf AG, Cytiva (uma subsidiária da Danaher Corporation), Glenmark Pharmaceutical Inc., EUA (uma subsidiária da Glenmark), EDGE pharma , Cook, SARSTEDT AG & Co. KG, Barkey, Boekel Scientific, LABCOLD, Sartorious AG e Helmer Scientific Inc., entre outros players nacionais. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

Muitos contratos e acordos são também iniciados pelas empresas de todo o mundo que também estão a acelerar o mercado de equipamentos de descongelação para terapia celular e genética.

Por exemplo,

  • Em novembro de 2020, a Eppendorg AG lançou o SmartBlock para descongelação de células na Índia. O Smart Block Cell Thawing é uma base para o processamento a jusante. É fácil e conveniente para os cientistas utilizarem posteriormente em todos os laboratórios de manipulação de células.

A colaboração, o lançamento de produtos, a expansão de negócios, a premiação e o reconhecimento, as joint ventures e outras estratégias do player de mercado estão a aumentar a presença da empresa no mercado de equipamentos de descongelação de terapia celular e genética, o que também oferece o benefício para o crescimento do lucro da organização.


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 USAGE OF THAWING EQUIPMENT IN UPSTREAM AND DOWNSTREAM PROCESSES

5.1 UPSTREAM PROCESS

5.2 DOWNSTREAM PROCESS

6 CELL AND GENE THERAPY WORKFLOW USING THAWING EQUIPMENT

7 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: REGULATIONS

7.1 CANADA

7.2 THE U.S.

7.3 EUROPE

7.4 GENE THERAPY LEGISLATION IN AUSTRIA

7.5 GENE THERAPY LEGISLATION IN BULGARIA

7.6 JAPAN

7.7 ITALY

7.8 MALAYSIA

8 REGIONAL SUMMARY

9 MARKET OVERVIEW

9.1 DRIVERS

9.1.1 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CYSTIC FIBROSIS AND SICKLE CELL ANEMIA

9.1.2 RISE IN INVESTMENT IN R&D FOR DEVELOPMENT OF CELL AND GENE THERAPIES

9.1.3 GOVERNMENT INITIATIVES FOR INITIATION OF CELL AND GENE THERAPY FIELD

9.1.4 INCREASED IMPLEMENTATION OF ADENO-ASSOCIATED VIRUS

9.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE THAWING SYSTEMS

9.2 RESTRAINTS

9.2.1 RISE IN COST ASSOCIATED WITH CELL AND GENE THERAPY ENGINEERING

9.2.2 RISE OF UNWANTED MUTAGENS

9.2.3 TECHNICAL HINDRANCE FACED IN USING THAWING INSTRUMENTS

9.2.4 STRICT REGULATORY FRAMEWORK

9.3 OPPORTUNITIES

9.3.1 INCREASING PREVALENCE OF CANCER

9.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS

9.3.3 RISE IN EXPENDITURE IN HEALTHCARE SECTOR

9.4 CHALLENGES

9.4.1 LONG APPROVAL TIME FOR IMMUNOTHERAPIES

9.4.2 LACK OF ACCESSIBILITY

10 IMPACT OF COVID-19 ON ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

10.1 IMPACT ON PRICE

10.2 IMPACT ON DEMAND

10.3 IMPACT ON SUPPLY CHAIN

10.4 STRATEGIC DECISION FOR MANUFACTURERS

10.5 CONCLUSION

11 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY

11.1 OVERVIEW

11.2 BENCH TOP

11.3 PORTABLE

12 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE

12.1 OVERVIEW

12.2 CELL THERAPIES

12.2.1 CAR T CELLS

12.2.2 NK CELLS

12.2.3 MSCS

12.2.4 TILS

12.2.5 OTHERS

12.3 GENE THERAPIES

12.3.1 ADENOVIRUS

12.3.2 ADENO-ASSOCIATED VIRUSES

12.3.3 LENTIVIRUSES

12.3.4 ONCOLYTIC VIRUSES

12.3.5 OTHERS

13 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE

13.1 OVERVIEW

13.2 AUTOMATIC THAWING SYSTEM

13.3 MANUAL THAWING SYSTEM

14 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION

14.1 OVERVIEW

14.2 UPSTREAM PROCESSING

14.2.1 AUTOMATIC THAWING SYSTEM

14.2.2 MANUAL THAWING SYSTEM

14.3 DOWNSTREAM PROCESSING

14.3.1 AUTOMATIC THAWING SYSTEM

14.3.2 MANUAL THAWING SYSTEM

15 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER

15.1 OVERVIEW

15.2 HOSPITALS AND DIAGNOSTIC LABORATORIES

15.3 BLOOD BANKS AND TRANSFUSION CENTERS

15.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES

15.5 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY

15.6 CORD BLOOD AND STEM CELL BANKS

15.7 GENE BANKS

15.8 OTHERS

16 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 DIRECT TENDER

16.3 THIRD PARTY DISTRIBUTORS

16.4 OTHERS

17 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION

17.1 ASIA-PACIFIC

17.1.1 CHINA

17.1.2 INDIA

17.1.3 JAPAN

17.1.4 SOUTH KOREA

17.1.5 AUSTRALIA

17.1.6 SINGAPORE

17.1.7 THAILAND

17.1.8 MALAYSIA

17.1.9 INDONESIA

17.1.10 PHILIPPINES

17.1.11 REST OF ASIA PACIFIC

18 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

19 SWOT ANALYSIS

20 COMPANY PROFILE

20.1 MERCK KGAA

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 PRODUCT PORTFOLIO

20.1.4 RECENT DEVELOPMENTS

20.2 EPPENDORF AG

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 PRODUCT PORTFOLIO

20.2.4 RECENT DEVELOPMENTS

20.3 SARTORIUS AG

20.3.1 COMPANY SNAPSHOT

20.3.2 REVENUE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENT

20.4 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)

20.4.1 COMPANY SNAPSHOT

20.4.2 REVENUE ANALYSIS

20.4.3 PRODUCT PORTFOLIO

20.4.4 .RECENT DEVELOPMENTS

20.5 BARKEY

20.5.1 COMPANY SNAPSHOT

20.5.2 PRODUCT PORTFOLIO

20.5.3 RECENT DEVELOPMENTS

20.6 BOEKEL SCIENTIFIC

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 BIOLINE INDIA

20.7.1 COMPANY SNAPSHOT

20.7.2 PRODUCT PORTFOLIO

20.7.3 RECENT DEVELOPMENTS

20.8 COOK

20.8.1 COMPANY SNAPSHOT

20.8.2 PRODUCT PORTFOLIO

20.8.3 RECENT DEVELOPMENT

20.9 GENESIS BPS

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENTS

20.1 HELMER SCIENTIFIC INC.

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENTS

20.11 LABCOLD

20.11.1 COMPANY SNAPSHOT

20.11.2 PRODUCT PORTFOLIO

20.11.3 RECENT DEVELOPMENTS

20.12 PLEURISTEM THERAPEUTICS INC.

20.12.1 COMPANY SNAPSHOT

20.12.2 REVENUE ANALYSIS

20.12.3 PRODUCT PORTFOLIO

20.12.4 RECENT DEVELOPMENTS

20.13 SARSTEDT AG & CO. KG

20.13.1 COMPANY SNAPSHOT

20.13.2 PRODUCT PORTFOLIO

20.13.3 RECENT DEVELOPMENTS

21 QUESTIONNAIRE

22 RELATED REPORTS

Lista de Tabela

TABLE 1 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)

TABLE 2 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 3 ASIA PACIFIC BENCH TOP IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 ASIA PACIFIC PORTABLE IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 6 ASIA PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 ASIA PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 8 ASIA PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 ASIA PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 10 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 11 ASIA PACIFIC AUTOMATIC THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 ASIA PACIFIC MANUAL THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 14 ASIA PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 ASIA PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 ASIA PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 ASIA PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 18 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 19 ASIA PACIFIC HOSPITALS AND DIAGNOSTIC LABORATORIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 ASIA PACIFIC BLOOD BANKS AND TRANSFUSION CENTERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 ASIA PACIFIC RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA PACIFIC BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA PACIFIC CORD BLOOD AND STEM CELL BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 ASIA PACIFIC GENE BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 ASIA PACIFIC OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 27 ASIA PACIFIC DIRECT TENDER IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA PACIFIC OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 42 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 43 CHINA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 44 CHINA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 45 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 CHINA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 CHINA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 49 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 50 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 52 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 53 INDIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 54 INDIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 55 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 57 INDIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 58 INDIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 59 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 62 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 63 JAPAN CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 64 JAPAN GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 65 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 JAPAN UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 JAPAN DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 70 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 72 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 73 SOUTH KOREA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 74 SOUTH KOREA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 75 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 76 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 77 SOUTH KOREA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 SOUTH KOREA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 80 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 81 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 82 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 83 AUSTRALIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 84 AUSTRALIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 85 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 86 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 87 AUSTRALIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 88 AUSTRALIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 90 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 91 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 92 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 93 SINGAPORE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 94 SINGAPORE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 95 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 96 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 SINGAPORE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 98 SINGAPORE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 99 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 100 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 101 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 102 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 103 THAILAND CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 104 THAILAND GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 105 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 106 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 107 THAILAND UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 THAILAND DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 109 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 110 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 111 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 112 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 113 MALAYSIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 114 MALAYSIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 115 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 116 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 117 MALAYSIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 118 MALAYSIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 119 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 120 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 121 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 122 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 123 INDONESIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 124 INDONESIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 125 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 126 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 127 INDONESIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 128 INDONESIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 129 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 130 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 131 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 132 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 133 PHILIPPINES CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 134 PHILIPPINES GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 135 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 136 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 137 PHILIPPINES UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 PHILIPPINES DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 139 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 140 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 141 REST OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

Lista de Figura

FIGURE 1 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DATA TRIANGULATION

FIGURE 3 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DROC ANALYSIS

FIGURE 4 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION

FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CARDIAC AILMENTS, CYSTIC FIBROSIS AND AIDS IS EXPECTED TO DRIVE THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN 2021 & 2028

FIGURE 15 PESTEL ANALYSIS

FIGURE 16 PORTERS FIVE FORCES MODEL

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

FIGURE 18 INCIDENCE OF CYSTIC FIBROSIS OBSERVED IN THE COUNTRIES

FIGURE 19 PREVALENCE OF SICKLE CELL ANEMIA IN AFRICA AND EUROPE

FIGURE 20 NEW CANCER CASES WORLDWIDE, (2018) (IN MILLION)

FIGURE 21 ASIA PACIFIC CANCER INCIDENCE (2018)

FIGURE 22 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2020

FIGURE 23 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2021-2028 (USD MILLION)

FIGURE 24 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, CAGR (2021-2028)

FIGURE 25 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 26 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2020

FIGURE 27 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2021-2028 (USD MILLION)

FIGURE 28 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, CAGR (2021-2028)

FIGURE 29 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY SAMPLE, LIFELINE CURVE

FIGURE 30 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2020

FIGURE 31 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2021-2028 (USD MILLION)

FIGURE 32 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, CAGR (2021-2028)

FIGURE 33 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 34 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2020

FIGURE 35 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 36 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 37 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 38 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2020

FIGURE 39 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 40 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 41 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 42 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 43 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 44 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 45 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 46 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SNAPSHOT (2020)

FIGURE 47 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020)

FIGURE 48 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 49 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 50 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY (2021-2028)

FIGURE 51 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENTMARKET: COMPANY SHARE 2020 (%)

FIGURE 52 COMPANY SHARE ANALYSIS

FIGURE 53 COMPANY SHARE ANALYSIS

FIGURE 54 COMPANY SHARE ANALYSIS

FIGURE 55 COMPANY SHARE ANALYSIS

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.